Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Works in Infectious disease · Respiratory

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) is a clinical trial sponsor. It has 3 active clinical trials with 11,110 planned participants, in Infectious disease and Respiratory. Since 2021 it has completed 6 trials and stopped 0 early.

Trial track record · since 2021

3Active trials11,110 planned participants
6Completed4 with results posted
0Stopped early0% of finished trials

Pipeline · 3 active trials

StageTrialStatus

Questions about Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.